Silverback Therapeutics, Inc. Contracts & Agreements

55 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Letter Agreement, by and between the registrant and Valerie Odegard, Ph.D., dated July 23, 2016
Silverback Therapeutics, Inc.
Biotechnology
2020
Second Amendment, dated September 17, 2024, to Manufacturing Agreement, dated September 9, 2020 and first amended July 25, 2023, by and between ARS Pharmaceuticals, Inc. and...
Silverback Therapeutics, Inc.
2024
Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Silverback Therapeutics, Inc.
2024
Non-Employee Director Compensation Policy, as amended
Compensation Agreements
Silverback Therapeutics, Inc.
2024
First Amendment, dated July 26, 2023, to Manufacturing Agreement, dated as September 9, 2020, by and between ARS Pharmaceuticals, Inc. and Renaissance Lakewood, LLC
Silverback Therapeutics, Inc.
2023
Executive Employment Agreement, by and between the Company and Brian T. Dorsey, effective as of October 1, 2018
Employment Agreements
Silverback Therapeutics, Inc.
2022
Manufacturing Agreement, dated as September 9, 2020, by and between ARS Pharmaceuticals, Inc. and Renaissance Lakewood, LLC
Silverback Therapeutics, Inc.
2022
Agreement and Plan of Merger and Reorganization, dated as of July 21, 2022, by and among Silverback Therapeutics, Inc., Sabre Merger Sub, Inc. and ARS Pharmaceuticals, Inc., as...
Merger Agreements
Silverback Therapeutics, Inc.
2022
Warrant to purchase stock issued to Silicon Valley Bank, dated as of September 30, 2019, as amended on December 7, 2020
Warrant Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2022
License Agreement, dated as of June 18, 2018, by and between ARS Pharmaceuticals, Inc. and Aegis Therapeutics, LLC, as amended by the First Amendment to License Agreement, dated...
License Agreements
Silverback Therapeutics, Inc.
2022
Collaboration and License Agreement, dated as of April 30, 2020, by and between ARS Pharmaceuticals, Inc. and Alfresa Pharma Corporation
Collaboration Agreements
Silverback Therapeutics, Inc.
Biotechnology
NY
2022
Collaboration and Distribution Agreement, dated as of March 1, 2021, by and between ARS Pharmaceuticals, Inc. and Pediatrix Therapeutics
Collaboration Agreements
Silverback Therapeutics, Inc.
Biotechnology
NY
2022
License and Supply Agreement, dated as of September 21, 2020, by and between ARS Pharmaceuticals, Inc. and Recordati Ireland, Ltd
License Agreements
Silverback Therapeutics, Inc.
2022
Executive Employment Agreement, dated as of September 14, 2018, by and between ARS Pharmaceuticals, Inc. and Richard E. Lowenthal
Employment Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2022
Executive Employment Agreement, dated as of February 9, 2022, by and between ARS Pharmaceuticals, Inc. and Kathleen Scott
Employment Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2022
Executive Employment Agreement, dated as of September 14, 2018, by and between ARS Pharmaceuticals, Inc. and Dr. Sarina Tanimoto, as amended by Amendment No. 1 to Executive...
Employment Agreements
Silverback Therapeutics, Inc.
2022
Executive Employment Agreement, dated as of February 16, 2022, by and between ARS Pharmaceuticals, Inc. and Eric Karas
Employment Agreements
Silverback Therapeutics, Inc.
Biotechnology
PA
2022
Executive Employment Agreement, dated as of June 1, 2019, by and between ARS Pharmaceuticals, Inc. and Justin Chakma
Employment Agreements
Silverback Therapeutics, Inc.
2022
Consulting Agreement, dated as of April 26, 2021, by and between ARS Pharmaceuticals, Inc. and Brenton L. Saunders, as amended on April 25, 2022
Consulting Agreements
Silverback Therapeutics, Inc.
2022
Consulting Agreement, by and between ARS Pharmaceuticals, Inc. and Marlinspike Group, LLC, dated September 14, 2018
Consulting Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2022
Consulting Agreement, by and between ARS Pharmaceuticals, Inc. and Pacific-Link Regulatory Consulting, Inc., dated July 1, 2022
Consulting Agreements
Silverback Therapeutics, Inc.
Biotechnology
2022
Consulting Services Agreement and Statement of Work No. 1, by and between the registrant and Jonathan Piazza, dated September 2, 2022
Consulting Agreements
Silverback Therapeutics, Inc.
2022
Consulting Services Agreement and Statement of Work No. 1, by and between the registrant and Valerie Odegard, dated September 2, 2022
Consulting Agreements
Silverback Therapeutics, Inc.
Biotechnology
WA
2022
Consulting Services Agreement and Statement of Work No. 1, by and between the registrant and Laura Shawver, Ph.D., dated September 2, 2022
Consulting Agreements
Silverback Therapeutics, Inc.
2022
Second Amendment to the Agreement and Plan of Merger and Reorganization, dated October 25, 2022, by and among Silverback Therapeutics, Inc., Sabre Merger Sub, Inc. and ARS...
Merger Agreements
Silverback Therapeutics, Inc.
Biotechnology
2022
Second Amendment to Lease, dated September 27, 2022, by and between the Company and BMR-500 Fairview Avenue LLC
Lease Agreements
Silverback Therapeutics, Inc.
Biotechnology
2022
Form of Silverback Therapeutics, Inc. Support Agreement, dated July 21, 2022
Silverback Therapeutics, Inc.
2022
Form of Lock-Up Agreement, dated July 21, 2022
Silverback Therapeutics, Inc.
Biotechnology
2022
Form of ARS Pharmaceuticals, Inc. Support Agreement, dated July 21, 2022
Silverback Therapeutics, Inc.
Biotechnology
CA
2022
Agreement and Plan of Merger and Reorganization, dated July 21, 2022, by and among Silverback Therapeutics, Inc., Sabre Merger Sub, Inc. and ARS Pharmaceuticals, Inc
Merger Agreements
Silverback Therapeutics, Inc.
Biotechnology
DE
2022
Non-Employee Director Compensation Policy, as amended
Compensation Agreements
Silverback Therapeutics, Inc.
2022
Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the Silverback Therapeutics, Inc. 2020 Equity Incentive Plan
Bonus & Incentive Agreements
Silverback Therapeutics, Inc.
2022
SUBLEASE AGREEMENT
Lease Agreements
Silverback Therapeutics, Inc.
2022
Sublease, by and between the registrant and Delta Dental, dated July 1, 2021
Lease Agreements
Silverback Therapeutics, Inc.
Biotechnology
WA
2021
Amendment No. 1 to Cell Line License Agreement, by and between the registrant and WuXi Biologics (Hong Kong) Limited, dated January 12, 2021
License Agreements
Silverback Therapeutics, Inc.
2021
Description of Registrants Common Stock
Stock Agreements
Silverback Therapeutics, Inc.
Biotechnology
2021
Silverback Therapeutics, Inc. 2020 Equity Incentive Plan, and Forms of Option Grant Notice, Option Agreement and Notice of Exercise thereunder
Bonus & Incentive Agreements
Silverback Therapeutics, Inc.
Biotechnology
DE
2020
Form of Underwriting Agreement
Underwriting Agreements
Silverback Therapeutics, Inc.
Biotechnology
2020
Form of Common Stock Certificate of the registrant
Stock Agreements
Silverback Therapeutics, Inc.
Biotechnology
2020
Silverback Therapeutics, Inc. 2020 Employee Stock Purchase Plan
Stock Agreements
Silverback Therapeutics, Inc.
Biotechnology
2020
Non-Employee Director Compensation Policy
Compensation Agreements
Silverback Therapeutics, Inc.
2020
Warrant to purchase stock issued to Silicon Valley Bank, dated November 21, 2016
Warrant Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2020
Amended and Restated Investors Rights Agreement, by and between the registrant and certain of its stockholders, dated September 22, 2020
Investor Rights Agreements
Silverback Therapeutics, Inc.
Biotechnology
DE
2020
Warrant to purchase stock issued to Silicon Valley Bank, dated December 22, 2017
Warrant Agreements
Silverback Therapeutics, Inc.
2020
Form of Indemnity Agreement, by and between the registrant and its directors and officers
Silverback Therapeutics, Inc.
2020
Silverback Therapeutics, Inc. 2016 Equity Incentive Plan, as amended, and Forms of Option Agreement, Notice of Exercise, Notice of Early Exercise, Restricted Stock Grant Notice...
Bonus & Incentive Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2020
Letter Agreement, by and between the registrant and Laura Shawver, Ph.D., dated March 6, 2020, as amended
Silverback Therapeutics, Inc.
Biotechnology
2020
Letter Agreement, by and between the registrant and Naomi Hunder, M.D., dated December 22, 2018
Silverback Therapeutics, Inc.
2020
Letter Agreement, by and between the registrant and Jonathan Piazza, dated November 3, 2020
Silverback Therapeutics, Inc.
Biotechnology
2020
Lease, by and between the registrant and BMR-500 Fairview Avenue LLC, dated June 8, 2016
Lease Agreements
Silverback Therapeutics, Inc.
2020
Master Laboratory Services Agreement, by and between the registrant and Q Squared Solutions LLC, dated May 25, 2020
Services Agreements
Silverback Therapeutics, Inc.
2020
Master Services Agreement, by and between the registrant and CE3, Inc., dated January 21, 2020
Services Agreements
Silverback Therapeutics, Inc.
Biotechnology
WA
2020
Cell Line License Agreement, by and between the registrant and WuXi Biologics (Hong Kong) Limited, dated October 11, 2019
License Agreements
Silverback Therapeutics, Inc.
Biotechnology
NY
2020
Loan and Security Agreement, by and between the registrant and Silicon Valley Bank, dated November 21, 2016, as amended
Loan Agreements
Silverback Therapeutics, Inc.
Biotechnology
CA
2020
Silverback Therapeutics, Inc. 2020 Change in Control and Severance Benefit Plan
Change of Control Agreements
Silverback Therapeutics, Inc.
2020